NCT07218367 2026-02-13Phase I Trial of pH Resections of GBM at VAVA Office of Research and DevelopmentPhase 1 Not yet recruiting12 enrolled
NCT00004688 2015-03-25Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain NeoplasmsFDA Office of Orphan Products DevelopmentPhase 2 Completed35 enrolled